Overview
Audrey Hamilton is an Oncologist in Denville, New Jersey. Dr. Hamilton is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Hodgkin Lymphoma.
Her clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Chronic B-Cell Leukemia (CBCL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Trustees Of Columbia University In The City Of New York
Nicole Lamanna is an Oncologist and a Hematologist in New York, New York. Dr. Lamanna is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy.
Weill Medical College Of Cornell
Richard Furman is a Hematologist and an Oncologist in New York, New York. Dr. Furman is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Bone Marrow Aspiration, and Lymphadenectomy.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaDr. Hamilton isDistinguished. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Hamilton isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Hamilton isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Classical Hodgkin LymphomaDr. Hamilton isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Hamilton isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Hamilton isDistinguished. Learn about Follicular Lymphoma.
- Advanced
- Familial Pancreatic CancerDr. Hamilton isAdvanced. Learn about Familial Pancreatic Cancer.
- Hairy Cell Leukemia (HCL)Dr. Hamilton isAdvanced. Learn about Hairy Cell Leukemia (HCL).
- Lung CancerDr. Hamilton isAdvanced. Learn about Lung Cancer.
- Lymphofollicular HyperplasiaDr. Hamilton isAdvanced. Learn about Lymphofollicular Hyperplasia.
- Lymphoid HyperplasiaDr. Hamilton isAdvanced. Learn about Lymphoid Hyperplasia.
- Marginal Zone Lymphoma (MZL)Dr. Hamilton isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Hamilton isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Appendix CancerDr. Hamilton isExperienced. Learn about Appendix Cancer.
- Basal Cell Skin CancerDr. Hamilton isExperienced. Learn about Basal Cell Skin Cancer.
- Breast CancerDr. Hamilton isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Hamilton isExperienced. Learn about Breast Cancer in Men.
- Childhood Acute Myeloid LeukemiaDr. Hamilton isExperienced. Learn about Childhood Acute Myeloid Leukemia.

